Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Surgical sees double-digit growth for Valleylab; Pfizer unit acquired for $425 mil. in cash.

This article was originally published in The Gray Sheet

Executive Summary

USSC EXPANDING ULTRASONIC PRESENCE WITH $425 MIL. PURCHASE OF VALLEYLAB from Pfizer, strengthening U.S. Surgical Corp.'s position in a rapidly growing segment of the surgical products market. During a Dec. 9 teleconference announcing the acquisition, USSC Chairman Leon Hirsch commented that while ultrasonics currently account for a small portion of Valleylab's product offerings, they are "likely to grow a lot faster" than the firm's core business.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009279

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel